Feedback / Questions
PN-881 - Protagonist Therap
PN-881: Initiation of P2 trial for hidradenitis suppurativa in 2027
(Protagonist Therapeutics)
-
May 10, 2026 -
Corporate Presentation
New P2 trial
•
Hidradenitis Suppurativa
https://investor.verastem.com/static-files/def839e5-6572-4a55-8777-210e1d4aa0cd
May 10, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious